Status:
COMPLETED
Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.
Lead Sponsor:
Pfizer
Conditions:
Diabetic Neuropathy, Painful
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To evaluate long-term efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy.
Eligibility Criteria
Inclusion
- Must have met the inclusion criteria for preceding double-blind study
- Must have received pregabalin or amitriptyline or placebo under double-blind conditions under double-blind conditions at least during first 3 weeks if double-blind treatment phase of preceding study.
Exclusion
- Patients cannot be included if they experienced a serious adverse event while participating in preceding double-blind study, which was determined to be related to the study medication.
Key Trial Info
Start Date :
September 1 1999
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00141401
Start Date
September 1 1999
End Date
July 1 2005
Last Update
August 17 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.